Stock symbol : 4519.T. Exchange : Tokyo. Currency : JPY Lastest price : 3,358.00￥. Total volume : 1.73M. Market state POSTPOST Click reload if you want to check the lastest price on market!!!
Chugai Pharmaceutical Co., Ltd. (4519.T)
|Bid||3,349.00 x N/A|
|Ask||3,358.00 x N/A|
|52 Week Range||3,191.00-4,320.00|
|Dividend (Yield %)||2.24%|
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, FoundationOne, Polivy, Rozlytrek, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, and Gazyva; osteoporosis, including Actemra, Edirol, and Bonviva; Mircera, an erythropoiesis agent; Oxarol, an agent for secondary hyperparathyr... oidism; and other diseases comprise Hemlibra, CellCept, Tamiflu, Evrysdi, Ronapreve, Vabysmo, and Enspryng. It has various development product candidates in the areas of oncology, immunology, neuroscience, hematology, ophthalmology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Chuo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.
News about "Chugai Pharmaceutical Co., Ltd."